BRIDGER MANAGEMENT, LLC Diversified Active

Location: New York, NY

CIK: 0001166309 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Mar 25, 2024

Total Value: $301M (100.0% shares, 0.0% debt)

Holdings (30)

UBER UBER TECHNOLOGIES INC 11.4%
Value $34.3M Shares 794,557 Share Price $43.17 * Est. Cost/Share $34.18 Unrealized @ Report Date +8.7%
MLCO MELCO RESORTS AND ENTMNT LTD 8.0%
Value $23.99M Shares 1,965,122 Share Price $12.21 Est. Cost/Share $11.32 Unrealized @ Report Date —
CZR CAESARS ENTERTAINMENT INC NE 7.9%
Value $23.68M Shares 464,525 Share Price $50.97 * Est. Cost/Share $44.10 Unrealized @ Report Date +3.0%
GDDY GODADDY INC 6.7%
Value $20.27M Shares 269,803 Share Price $75.13 Est. Cost/Share $39.71 Unrealized @ Report Date +86.0%
CHTR CHARTER COMMUNICATIONS INC N 6.2%
Value $18.7M Shares 50,913 Share Price $367.37 * Est. Cost/Share $304.75 Unrealized @ Report Date +12.0%
MS MORGAN STANLEY 5.2%
Value $15.54M Shares 181,914 Share Price $85.40 * Est. Cost/Share $34.65 Unrealized @ Report Date +126.2%
ALC ALCON AG 5.0%
Value $14.94M Shares 181,977 Share Price $82.11 * Est. Cost/Share $66.73 Unrealized @ Report Date +13.5%
VRTX VERTEX PHARMACEUTICALS INC 4.9%
Value $14.92M Shares 42,400 Share Price $351.91 * Est. Cost/Share $336.94 Unrealized @ Report Date 0.0%
BBWI BATH & BODY WORKS INC 4.6%
Value $13.95M Shares 372,100 Share Price $37.50 * Est. Cost/Share $33.87 Unrealized @ Report Date 0.0%
BIIB BIOGEN INC 4.4%
Value $13.28M Shares 46,633 Share Price $284.85 * Est. Cost/Share $281.57 Unrealized @ Report Date +5.8%
LLY LILLY ELI & CO 4.4%
Value $13.17M Shares 28,076 Share Price $468.98 * Est. Cost/Share $411.47 Unrealized @ Report Date 0.0%
BMRN BIOMARIN PHARMACEUTICAL INC 4.1%
Value $12.39M Shares 142,979 Share Price $86.68 * Est. Cost/Share $83.83 Unrealized @ Report Date +12.3%
TEVA TEVA PHARMACEUTICAL INDS LTD 3.7%
Value $11.29M Shares 1,500,000 Share Price $7.53 Est. Cost/Share $28.21 Unrealized @ Report Date —
USFD US FOODS HLDG CORP 3.6%
Value $10.84M Shares 246,431 Share Price $44.00 * Est. Cost/Share $39.68 Unrealized @ Report Date 0.0%
— CATALENT INC 3.5%
Value $10.46M Shares 241,338 Share Price $43.36 Est. Cost/Share $43.36 Unrealized @ Report Date —
— IMMUNOGEN INC 2.9%
Value $8.816M Shares 467,220 Share Price $18.87 Est. Cost/Share $18.87 Unrealized @ Report Date —
DCBO DOCEBO INC 1.8%
Value $5.492M Shares 138,592 Share Price $39.63 * Est. Cost/Share $46.87 Unrealized @ Report Date -22.7%
BLCO BAUSCH PLUS LOMB CORP 1.6%
Value $4.926M Shares 245,431 Share Price $20.07 * Est. Cost/Share $18.14 Unrealized @ Report Date 0.0%
SHC SOTERA HEALTH CO 1.6%
Value $4.906M Shares 260,400 Share Price $18.84 * Est. Cost/Share $15.89 Unrealized @ Report Date 0.0%
CCK CROWN HLDGS INC 1.6%
Value $4.787M Shares 55,100 Share Price $86.87 * Est. Cost/Share $79.93 Unrealized @ Report Date 0.0%
— FLAME ACQUISITION CORP 1.5%
Value $4.55M Shares 443,000 Share Price $10.27 Est. Cost/Share $9.75 Unrealized @ Report Date —
QTRX QUANTERIX CORP 1.2%
Value $3.493M Shares 154,900 Share Price $22.55 * Est. Cost/Share $12.78 Unrealized @ Report Date +39.5%
— WILLIAMS ROWLAND ACQUISITION 1.0%
Value $3.08M Shares 297,000 Share Price $10.37 Est. Cost/Share $9.91 Unrealized @ Report Date —
KNF KNIFE RIVER CORP 1.0%
Value $2.967M Shares 68,199 Share Price $43.50 * Est. Cost/Share $44.43 Unrealized @ Report Date 0.0%
— REATA PHARMACEUTICALS INC 0.8%
Value $2.529M Shares 24,800 Share Price $101.96 Est. Cost/Share $90.92 Unrealized @ Report Date —
GOOGL ALPHABET INC 0.6%
Value $1.664M Shares 13,900 Share Price $119.70 * Est. Cost/Share $95.22 Unrealized @ Report Date +20.0%
QURE UNIQURE NV 0.4%
Value $1.272M Shares 111,000 Share Price $11.46 * Est. Cost/Share $18.95 Unrealized @ Report Date 0.0%
TOST TOAST INC 0.4%
Value $1.189M Shares 52,692 Share Price $22.57 * Est. Cost/Share $17.34 Unrealized @ Report Date +15.1%
— SURROZEN INC 0.0%
Value $33,934 Shares 61,699 Share Price $0.55 Est. Cost/Share $5.99 Unrealized @ Report Date —
SRZNW SURROZEN INC 0.0%
Value $25,760 Shares 466,666 Share Price $0.06 Est. Cost/Share $0.76 Unrealized @ Report Date —